Skip to main content

Table 2 Top ten domestic production pharmaceutical companies in Iran; 2016

From: The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016

Rank

Company

Sales ($)

Market share (%)

Cumulative share (%)

Ownership

1

Dr Abidi

173,194,903

4.59

4.59

Private

2

Darou Pakhsh Pharma

169,064,903

4.48

9.07

Public

3

Actover

139,703,765

3.70

12.78

Private

4

Exir Pharma

133,209,646

3.53

16.31

Public

5

Dana

131,028,469

3.47

19.79

Public

6

Zahravi

124,236,571

3.29

23.08

Public

7

Alborz Darou

117,867,586

3.13

26.20

Public

8

Jaber Ebne Hayyan

114,024,975

3.02

29.23

Public

9

Cinagen

113,924,849

3.02

32.25

Private

10

Tehran Chemie

102,912,559

2.73

34.98

Private